Yayın:
Atezolizumab combined with chemotherapy in the first-line treatment of extensive-stage small cell lung cancer: a real-life data of the Turkish Oncology Group

dc.contributor.authorTurhal, N. S.
dc.contributor.authorÜskent, Necdet
dc.contributor.authorErman Akkuş
dc.contributor.authorElif Berna Köksoy
dc.contributor.authorNaziyet Köse
dc.contributor.authorBala Başak Öven
dc.contributor.authorBaşak Oyan Uluç
dc.contributor.authorAtike Gökçen Demiray
dc.contributor.authorDi̇lek Erdem
dc.contributor.authorBilgin Demir
dc.contributor.authorN. S. Turhal
dc.contributor.authorNecdet Üskent
dc.contributor.authorSinem Akbaş
dc.contributor.authorFatih Selçukbırıcık
dc.contributor.authorAli İnal
dc.contributor.authorAhmet Bılıcı
dc.contributor.authorÖmer Fatih Ölmez
dc.contributor.authorDevrim Çabuk
dc.contributor.authorÇağlar Ünal
dc.contributor.authorMutlu Hızal
dc.contributor.authorMehmet Alı Nahıt Şendur
dc.contributor.authorMustafa Korkmaz
dc.contributor.authorNuri Karadurmuş
dc.contributor.authorİsmail Ertürk
dc.contributor.authorSema Sezgin Göksu
dc.contributor.authorAli Murat Tatlı
dc.contributor.authorDeniz Can Güven
dc.contributor.authorSaadettin Kılıçkap
dc.contributor.authorNail Paksoy
dc.contributor.authorAdnan Aydıner
dc.contributor.authorHavva Yeşil Çınkır
dc.contributor.authorÖzlem Özkul
dc.contributor.authorAkın Öztürk
dc.contributor.authorSevinç Ballı
dc.contributor.authorYasemi̇n Kemal
dc.contributor.authorAtike Pınar Erdoğan
dc.contributor.authorÖzlem Er
dc.contributor.authorPerran Fulden Yumuk
dc.contributor.authorAhmet Demirkazık
dc.contributor.orcid0000-0001-7680-4142
dc.contributor.orcid0000-0003-2184-634X
dc.contributor.orcid0000-0002-7531-7817
dc.contributor.orcid0000-0002-6590-4444
dc.contributor.orcid0000-0002-6623-6273
dc.contributor.orcid0000-0003-4397-5468
dc.contributor.orcid0000-0001-6495-6712
dc.contributor.orcid0000-0003-4380-9419
dc.contributor.orcid0000-0002-1013-5676
dc.contributor.orcid0000-0003-2739-7362
dc.contributor.orcid0000-0002-1273-1674
dc.contributor.orcid0000-0001-9510-9858
dc.contributor.orcid0000-0002-0443-6966
dc.contributor.orcid0000-0001-7934-7039
dc.contributor.orcid0000-0002-7871-6311
dc.contributor.orcid0000-0003-3245-1570
dc.contributor.orcid0000-0001-5147-4431
dc.contributor.orcid0000-0001-7021-6139
dc.contributor.orcid0000-0003-0926-6748
dc.contributor.orcid0000-0003-3291-8062
dc.contributor.orcid0000-0003-3204-4430
dc.contributor.orcid0000-0002-8026-764X
dc.contributor.orcid0000-0001-9696-1102
dc.contributor.orcid0000-0002-6924-9467
dc.contributor.orcid0000-0003-1637-7390
dc.contributor.orcid0000-0003-4636-2595
dc.contributor.orcid0000-0002-1104-5840
dc.contributor.orcid0000-0002-7870-8741
dc.contributor.orcid0000-0003-4413-0133
dc.contributor.orcid0000-0002-3445-3804
dc.contributor.orcid0000-0002-1175-9085
dc.contributor.orcid0000-0003-4859-7574
dc.contributor.orcid0000-0002-9272-2400
dc.contributor.orcid0000-0001-8650-299X
dc.contributor.orcid0000-0002-2917-7999
dc.date.accessioned2025-11-13T10:21:22Z
dc.date.issued2022-06-11
dc.identifier.doihttps://doi.org/10.1007/s00432-022-04087-x
dc.identifier.endpage3555
dc.identifier.issn0171-5216
dc.identifier.issue12
dc.identifier.openalexW4282927265
dc.identifier.startpage3547
dc.identifier.urihttps://hdl.handle.net/11421/3898
dc.identifier.urihttps://doi.org/10.1007/s00432-022-04087-x
dc.identifier.volume148
dc.language.isoen
dc.relation.ispartofJournal of Cancer Research and Clinical Oncology
dc.rightsopenAccess
dc.subjectAtezolizumab
dc.subjectMedicine
dc.subjectInternal medicine
dc.subjectOncology
dc.subjectLung cancer
dc.subjectChemotherapy
dc.subjectUnivariate analysis
dc.subjectStage (stratigraphy)
dc.subjectCancer
dc.subjectMultivariate analysis
dc.subjectImmunotherapy
dc.subjectPembrolizumab
dc.subject.sdg3
dc.titleAtezolizumab combined with chemotherapy in the first-line treatment of extensive-stage small cell lung cancer: a real-life data of the Turkish Oncology Group
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5064011743
local.authorid.openalexA5064757657

Dosyalar

Koleksiyonlar